Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Welschof is active.

Publication


Featured researches published by Martin Welschof.


Journal of Immunological Methods | 1995

Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes

Martin Welschof; Peter Terness; F. Kolbinger; Zewe M; Stefan Dübel; Heinz Dörsam; C. Hain; M. Finger; M Jung; Gerhard Moldenhauer; N. Hayashi; Melvyn Little; Gerhard Opelz

Previously described primers for PCR amplification of variable immunoglobulin (Ig) genes were based on gene sequences. To include the large number of amino acid sequences of antibodies whose DNA has not been sequenced and to ensure a maximal fit to rearranged human Ig variable region genes, we have made a comprehensive comparison of both protein and nucleotide sequences. The resulting set of 15 primers was able to amplify a wide range of rearranged antibody variable region genes. Restriction sites included in the primers facilitate cloning of the PCR products into various expression vectors. Sequence analyses of PCR-amplified cDNA derived from a polyclonal B cell population showed that maximal enrichment is obtained for highly represented variable Ig gene subgroups. Rarely occurring V kappa 4 and V lambda 5 subgroups were not detected. Rearranged Ig variable region genes from each of 19 human B cell lines were also amplified. Comparisons to germline sequences allowed the allocation of rearranged genes to the original Ig genes. This primer set should be very useful for generating large repertoires of rearranged V genes and for amplifying genes of individual B cell clones.


Journal of Immunological Methods | 1999

Generation of a large complex antibody library from multiple donors

Melvyn Little; Martin Welschof; Michael Braunagel; Ingrid Hermes; Christiane Christ; Armin Keller; Petra Rohrbach; Timo Kürschner; Stefanie Schmidt; Christian Kleist; Peter Terness

We have generated a large complex library of single chain antibodies based on four individual libraries from each of 50 donors. DNA coding for the heavy and light chain variable domains of the IgM and IgG repertoires was amplified by PCR using two different sets of primers. Each individual library was composed of approximately 1-5x10(7) independent clones giving a final combined library of 4x10(9) members. Screening this library by phage display of single chain antibodies with small haptens, peptides and proteins yielded specific antibodies for each class of antigen.


Journal of Immunological Methods | 1994

Isolation of IgG antibody Fv-DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers

Stefan Dübel; Frank Breitling; Patrick Fuchs; Mona Zewe; Stefanie Gotter; Martin Welschof; Gerhard Moldenhauer; Melvyn Little

To facilitate the isolation of IgG antibody Fv-DNA sequences from hybridoma cell lines, we have established a polymerase chain reaction (PCR) procedure requiring only a small number of primers. The sense primers homologous to DNA coding for the first framework sequences were designed to hybridize to all the known antibody sequences under conditions that permit a high number of mismatches. The antisense primers were homologous to DNA coding for the beginning of the constant regions of the gamma and kappa chains. Restriction sites introduced by the primers enable the DNA to be cloned into bacterial expression vectors. Only three sense VH primers and two sense VL primers paired with one backward primer for the heavy and light chains, respectively, were necessary for the amplification of Fv-DNA from a total of 17 rodent cell lines that we have so far worked with. These consisted of 12 mouse cell lines and five rat cell lines. This procedure will therefore probably be sufficient to isolate the Fv-DNA from most mouse cell lines and possibly also from most rat cell lines.


Immunotechnology | 1997

Cloning and cytotoxicity of a human pancreatic RNase immunofusion

Monika Zewe; Susanna M. Rybak; Stefan Dübel; Johannes F. Coy; Martin Welschof; Dianne L. Newton; Melvyn Little

BACKGROUND Immunotoxins based on plant and bacterial proteins are usually very immunogenic. Human ribonucleases could provide an alternative basis for the construction of less immunogenic reagents. Two members of the human RNase family, angiogenin and eosinophil-derived neurotoxin (EDN), have been fused to a single chain antibody against the transferrin receptor, which is known to be internalised by endocytosis. The fusion proteins proved to be very efficient inhibitors of protein synthesis using various cell lines. It is not yet known whether the side effects of angiogenin and EDN will compromise their potential use as immunotoxins. OBJECTIVES The goal of this work was to construct a human immunotoxin with no harmful side effects. Bovine pancreatic ribonuclease has been shown to be as potent as ricin at abolishing protein synthesis on injection into oocytes. We therefore decided to clone its human analogue, which is fairly ubiquitous and per se non-toxic. An immunofusion of human pancreatic RNase with a single chain antibody against the transferrin receptor was tested for its ability to inhibit protein synthesis in three different human tumor cell lines. STUDY DESIGN DNA coding for the human pancreatic RNase was cloned partially from a human fetal brain cDNA library and then completed by PCR using a human placental cDNA library as a template. The RNase gene was then fused with a DNA coding for an single chain antibody against the transferrin receptor (CD71). After expressing the fusion protein in E. coli, the gene product was isolated from inclusion bodies and tested for cytotoxicity. RESULTS This fusion protein inhibited the protein synthesis of three human tumor cell lines derived from a melanoma, a renal carcinoma and a breast carcinoma, with IC50s of 8, 5 and 10 nM, respectively. These values were comparable with those using a similar fusion protein constructed with eosinophil derived neurotoxin (EDN) as the toxic moiety (IC50s of 8, 1.2 and 3 nM, respectively). The slightly lower activities of the human pancreatic RNase-scFv (pancRNase-scFv) with two of the cell lines suggests that fewer molecules are reaching the cytoplasmic compartment, since it was twice as active as EDN-scFv in inhibiting the protein synthesis of a rabbit reticulocyte lysate. CONCLUSION These results demonstrate that the human pancreatic RNase, which is expected to have a very low immunogenic potential in humans with no inherent toxicity, may be a potent cytotoxin for tumor cells after antibody targeting.


FEBS Letters | 1997

Antibodies to steroids from a small human naive IgM library

Heinz Dörsam; Petra Rohrbach; Timo Kürschner; Sergey Kipriyanov; Stefanie Renner; Michael Braunagel; Martin Welschof; Melvyn Little

Human antibodies specific for digoxigenin, estradiol, testosterone and progesterone have been isolated from a small combinatorial IgM repertoire (4×107) of single chain antibodies (scFv). The affinities of both the anti‐estradiol and anti‐progesterone scFv were approximately 108 M−1. Naive IgM genes appeared to be highly represented, since only the heavy chain variable domain of the anti estradiol antibody contained differences to corresponding germline sequences. The light chain variable domain of the progesterone receptor was also identical to a germline sequence, showing that it is possible for completely naive antibodies to bind steroids with affinities comparable to those obtained after a secondary immune response.


Journal of Immunological Methods | 1998

Monitoring of scFv selected by phage display using detection of scFv-pIII fusion proteins in a microtiter scale assay.

Michael Mersmann; Alexej Schmidt; Michael Tesar; Annette Schöneberg; Martin Welschof; Sergej Kipriyanov; Peter Terness; Melvyn Little; Klaus Pfizenmaier; Dieter Moosmayer

We describe here a method for the efficient and rapid analysis of antigen binding characteristics of recombinant antibodies (ab) selected by phage display. This novel approach combines the bacterial production of soluble single chain ab (scFv)-pIII fusion proteins on a microtiter scale with the detection of these fusion proteins via a pIII-specific ab. It facilitates the parallel analysis of large numbers of clones and is more efficient than current analysis protocols. Applying this technique, we analysed phage display selection of tetanus toxoid (TTX) specific scFv with respect to: (i) the productive expression of fusion proteins; (ii) the enrichment of specific scFv in subsequent rounds of phage display selection on a polyclonal level; (iii) the antigen specificity of individual scFv clones; (iv) the antigen binding affinity of a selected scFv. A TTX-specific scFv (clone 4.3) was further examined in a mono- and bivalent form by surface plasmon resonance analysis. ScFv 4.3 possesses a subnanomolar affinity and a low off rate constant.


Methods in molecular medicine | 1998

Screening of phage-displayed antibody libraries.

Heinz Dörsam; Michael Braunagel; Christian Kleist; Daniel Moynet; Martin Welschof

The problem of amplifying a specific antibody in a population of millions of other antibodies has been solved by the immune system using the process of clonal selection Binding of an antigen to an IgM receptor on the surface of B-lymphocytes stimulates the proliferation and differentiation of the lymphocyte until it matures to an IgG-producing plasma cell. To mimic the first step of this process in bacteria, vectors have been constructed for the expression of antibodies on the surface of bacteria and phages (for review see Chapter 32 ).


Proceedings of the National Academy of Sciences of the United States of America | 1997

The antigen-binding domain of a human IgG-anti-F(ab′)2 autoantibody

Martin Welschof; Peter Terness; Sergey Kipriyanov; Diana Stanescu; Frank Breitling; Heinz Dörsam; Stefan Dübel; Melvyn Little; Gerhard Opelz


BioTechniques | 1994

Simultaneous mutagenesis of antibody CDR regions by overlap extension and PCR.

N. Hayashi; Martin Welschof; Zewe M; Michael Braunagel; Stefan Dübel; Frank Breitling; Melvyn Little


Journal of Immunology | 1995

The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope.

Peter Terness; I Kohl; Gerd Hübener; Roberto Battistutta; Luis Moroder; Martin Welschof; C Dufter; M Finger; C Hain; M Jung

Collaboration


Dive into the Martin Welschof's collaboration.

Top Co-Authors

Avatar

Melvyn Little

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heinz Dörsam

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Michael Braunagel

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Sergey Kipriyanov

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Stefan Dübel

Braunschweig University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge